Notice bibliographique
Résumé
Life Support Device Receives FDA Approval Abbott has received two clearances from the Food & Drug Administration for its CentriMag life support system. The system's blood pump had previously been approved for use up to six hours, but this has been expanded to allow for longer usage by physicians who are assessing patients who require extracorporeal membrane oxygenation (ECMO). The device provides physicians time for critical care decision-making for patients whose hearts are not able to pump enough blood on their own, according to a company press release. (Abbott. April 25,2023; https://bit.ly/3pmcNmj.) The life support device has been used to treat patients who have had open heart surgery and COVID-19 and for those who require ECMO support. Abbott also received clearance for a multisystem life support pack that includes the blood pump and an oxygenator intended for short-term cardiopulmonary support. The preconnected pack reduces the number of steps taken by physicians when providing critical care. Find more information about the CentriMag system at www.abbott.com.Figure: life support system, Abbott, CentriMag, blood pump, extracorporeal membrane oxygenation, ECMO, COVID-19, cardiopulmonary support, pain management, migraine, Nerivio, Theranica, remote electrical modulation, REN, nervous system, nanotechnology, respiratory infection, PCR, QolorEx, influenzaPain Management for Migraine The FDA has granted clearance to the Nerivio wearable for acute and preventive treatment of migraines. Theranica's neuromodulation device is a physician-prescribed, drug-free alternative to traditional migraine treatments that users wrap around the upper arm, where the device activates internal pain management by dispensing remote electrical modulation (REN) to the nervous system. A total of 248 participants were instructed to use either REN with the Nerivio wearable or a placebo every other day for eight weeks as part of a double-blind, randomized, placebo-controlled clinical trial. Participants using Nerivio experienced four fewer migraine days per month from baseline compared with the placebo group, who experienced 1.3 fewer migraine days per month, reported the company. (PRNewswire. Feb. 28, 2023; https://bit.ly/3XvVZ8O.) The treatment lasts 45 minutes. The drug-free device is an alternative pain management system for migraines that has no adverse effects, making the device a viable option for adolescents and pregnant individuals, who are reluctant to take medication due to concerns about effects on the fetus, a Medscape article reported. (June 23, 2023; https://bit.ly/3CVw3dr.) Visit www.theranica.com for more information. Diagnostic Nanotechnology for Respiratory Infection A startup from McGill University, Beeta Biomed, Inc., has developed a prototype diagnostic and molecular PCR test called QolorEX for detecting respiratory infections such as influenza A and B and COVID-19. The test device uses colorimetric detection of RNA to identify viruses from a saliva sample and injects light-excited hot electrons from the surface of a nanoplasmonic sensor to increase the speed of the test, reported Medscape. (June 20, 2023; https://bit.ly/3XzVr1Z.) The user inserts the cartridge with the saliva sample into an imaging system that then delivers results automatically to a computer or smart device within 15 minutes without the need to ship samples to a lab for testing. The system does not require users to mix reagents manually, reducing the risk of user error that could yield false results. The device can detect different variants of H1N1 influenza and SARS-CoV-2. The device detected positive COVID-19 cases with 99% specificity in a preclinical test of 33 participants, according to a company release. (McGill. April 18, 2023; https://bit.ly/435gFWu.) The developmental team said it anticipates partnering with a manufacturing company to make the test commercially available, and said they see the potential for it to detect bacterial infections and even cancer in the future. Visit www.mcgill.ca for more information. MS. TALBOT is an editorial assistant for Emergency Medicine News. Share this article on Twitter and Facebook. Access the links in EMN by reading this on our website: www.EM-News.com. Comments? Write to us at [email protected].
Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.
Comment cette classification a été obtenuedéplier
Prédiction distillée sur la base complète
Imitation des enseignantsNi prévalence calibrée, ni vérité terrain. Validation humaine à venir. Apprise à partir de 10 348 étiquettes directes de Codex et de 10 348 étiquettes directes de Gemma. Le mode candidate est l'union des têtes enseignantes seuillées; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont ni des étiquettes humaines ni des étiquettes directes de modèles de pointe.
Scores Codex et Gemma par catégorie
| Catégorie | Codex | Gemma |
|---|---|---|
| Métarecherche | 0,000 | 0,001 |
| Méta-épidémiologie (sens strict) | 0,000 | 0,000 |
| Méta-épidémiologie (sens large) | 0,000 | 0,000 |
| Bibliométrie | 0,001 | 0,002 |
| Études des sciences et des technologies | 0,000 | 0,000 |
| Communication savante | 0,000 | 0,000 |
| Science ouverte | 0,000 | 0,000 |
| Intégrité de la recherche | 0,000 | 0,000 |
| Charge utile insuffisante (le modèle a refusé de juger) | 0,003 | 0,002 |
Scores machine (provisoires)
Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.
Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.
score_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découleClassification
machine, non validéePrédiction automatique; les deux têtes enseignantes s’accordent sur ce qui est montré ici.
Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».